ATE222600T1 - Expression von rekombinantem hämoglobin in hefe - Google Patents

Expression von rekombinantem hämoglobin in hefe

Info

Publication number
ATE222600T1
ATE222600T1 AT91908364T AT91908364T ATE222600T1 AT E222600 T1 ATE222600 T1 AT E222600T1 AT 91908364 T AT91908364 T AT 91908364T AT 91908364 T AT91908364 T AT 91908364T AT E222600 T1 ATE222600 T1 AT E222600T1
Authority
AT
Austria
Prior art keywords
yeast
hemoglobin
globin
heme
substantially homologous
Prior art date
Application number
AT91908364T
Other languages
English (en)
Inventor
Angelo Joseph De
Nalini M Motwani
Wajeeh Bajwa
Original Assignee
Apex Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apex Bioscience Inc filed Critical Apex Bioscience Inc
Application granted granted Critical
Publication of ATE222600T1 publication Critical patent/ATE222600T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT91908364T 1990-04-16 1991-04-15 Expression von rekombinantem hämoglobin in hefe ATE222600T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US50991890A 1990-04-16 1990-04-16
US61435990A 1990-11-14 1990-11-14
US68461191A 1991-04-12 1991-04-12
PCT/US1991/002568 WO1991016349A1 (en) 1990-04-16 1991-04-15 Expression of recombinant hemoglobin in yeast

Publications (1)

Publication Number Publication Date
ATE222600T1 true ATE222600T1 (de) 2002-09-15

Family

ID=27414428

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91908364T ATE222600T1 (de) 1990-04-16 1991-04-15 Expression von rekombinantem hämoglobin in hefe

Country Status (11)

Country Link
EP (1) EP0537160B1 (de)
JP (1) JPH07504645A (de)
AT (1) ATE222600T1 (de)
AU (1) AU7744491A (de)
CA (1) CA2080589A1 (de)
DE (1) DE69133089T2 (de)
IE (1) IE911268A1 (de)
IL (1) IL97869A0 (de)
NZ (1) NZ237827A (de)
PT (1) PT97383B (de)
WO (1) WO1991016349A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022849A (en) * 1987-05-16 2000-02-08 Baxter Biotech Technology Saarl Mutant recombinant hemoglobins containing heme pocket mutations
US6204009B1 (en) 1988-05-16 2001-03-20 BAXTER BIOTECH TECHNOLOGY SàRL Nucleic acids encoding mutant recombinant hemoglobins containing heme pocket mutations
US5844090A (en) * 1994-05-09 1998-12-01 Somatogen, Inc. Modified hemoglobin-like compounds
US6150506A (en) * 1989-05-10 2000-11-21 Baxter Biotech Technology Sarl Modified hemoglobin-like compounds and methods of purifying same
US5545727A (en) * 1989-05-10 1996-08-13 Somatogen, Inc. DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin
US5840851A (en) * 1993-07-23 1998-11-24 Plomer; J. Jeffrey Purification of hemoglobin
IS4198A (is) * 1993-08-13 1995-02-14 Somatogen, Inc Meðferð vegna aukaverkana sem tengjast gjöf á utanfrumublóðrauða
US5665869A (en) * 1993-11-15 1997-09-09 Somatogen, Inc. Method for the rapid removal of protoporphyrin from protoporphyrin IX-containing solutions of hemoglobin
US5756295A (en) * 1994-12-05 1998-05-26 Takeda Chemical Industries, Ltd. DNA primer and a method for screening DNAS
CA2231245A1 (en) * 1995-10-23 1997-05-01 Mark S. Hargrove Hemoglobin mutants that reduce heme loss
US6812207B1 (en) 1995-10-23 2004-11-02 William Marsh Rice University Hemoglobin mutants that reduce heme loss
CA2236794A1 (en) * 1995-11-30 1997-06-05 Bruce A. Kerwin Method for control of functionality during cross-linking of hemoglobins
EP0868521A2 (de) 1995-12-22 1998-10-07 Somatogen Inc. Globinen mit bindenden domänen
JP6509884B2 (ja) * 2014-01-30 2019-05-08 チルドレンズ ホスピタル メディカル センター 鎌状赤血球病の遺伝子的是正のための改善された胎児ヘモグロビン
CA3145687A1 (en) * 2019-08-01 2021-02-04 Tippi MACKENZIE Compositions and methods for treating alpha thalassemia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840896A (en) * 1983-11-02 1989-06-20 Integrated Genetics, Inc. Heteropolymeric protein
NL8403425A (nl) * 1984-11-09 1986-06-02 Stichting Gastransport Stromavrije hemoglobine-oplossing, werkwijze voor de bereiding daarvan en toepassing daarvan.
US4826957A (en) * 1985-07-12 1989-05-02 New York University Immunogenic recombinant yeast expression product and method for purifying it
GB8711614D0 (en) * 1987-05-16 1987-06-24 Medical Res Council Proteins
IE970086A1 (en) * 1989-05-10 2000-02-23 Somatogenetics Internat Inc Production in bacteria and yeast of hemoglobin and analogues thereof
WO1991013158A1 (en) * 1990-02-28 1991-09-05 Delta Biotechnology Limited Protein production in yeast

Also Published As

Publication number Publication date
DE69133089T2 (de) 2003-04-17
AU7744491A (en) 1991-11-11
PT97383B (pt) 1998-08-31
EP0537160A4 (en) 1993-09-01
DE69133089D1 (de) 2002-09-26
IL97869A0 (en) 1992-06-21
WO1991016349A1 (en) 1991-10-31
EP0537160B1 (de) 2002-08-21
IE911268A1 (en) 1991-10-23
JPH07504645A (ja) 1995-05-25
NZ237827A (en) 1994-03-25
EP0537160A1 (de) 1993-04-21
PT97383A (pt) 1991-12-31
CA2080589A1 (en) 1991-10-17

Similar Documents

Publication Publication Date Title
ATE222600T1 (de) Expression von rekombinantem hämoglobin in hefe
GB8711614D0 (en) Proteins
ATE246246T1 (de) Herstellung von hämoglobin und analogen davon in nicht-erythrozytzellen
MX165652B (es) Materiales polimericos con elevada permeabilidad al oxigeno y baja sustantividad proteinica
ATE162802T1 (de) Amyloid-peptide
BR9915651A (pt) Processo para a preparação de ácidos alcanossulfÈnicos.
SE7601567L (sv) Polyhemoglobin
NO178653C (no) Fremgangsmåte for fremstilling av liposomer og/eller biologiske celler, i hvilke er inkludert tilsetningstoffer
ES2053758T3 (es) Una nueva molecula polipeptidica.
Buchanan A cystine-rich protein fraction from oxidized alpha-keratin
ATE421535T1 (de) Peg-modifiziertes erythropoietin
SG65593A1 (en) Totally synthetic affinity reagents
ATE252825T1 (de) Verlängerte lagerung roter blutzellen
ATE294865T1 (de) Identifizierung, produktion und verwendung von staphylokinase derivaten mit reduzierter immunogenizität und/oder reduzierter 'clearance'
Bridges Bohr and root effects in cephalopod haemocyanins‐paradox or pressure in Sepia officinalis?
Katsumata et al. Simultaneous determination of carboxyhemoglobin and methemoglobin in victims of carbon monoxide poisoning
IL90146A0 (en) Variants of plasminogen activators and processes for their production
CA2067371A1 (en) Stable hemoglobin based composition and method to store same
ATE102994T1 (de) Verfahren zur herstellung von proteinen.
Dawson et al. Magnetic circular dichroism studies. 43. Oxidized cytochrome P-450. Magnetic circular dichroism evidence for thiolate ligation in the substrate-bound form. Implications for the catalytic mechanism
ATE283288T1 (de) Mutantes hämoglobin mit niedriger affinität für sauerstoff
ATE140389T1 (de) Hämoglobin-oligomer basierte komposition und seine herstellung
RU96109508A (ru) Способ лечения отравлений, вызванных фосфороорганическими веществами
DE69935071D1 (de) Mutein von humanem Thrombopoietin
EP1950298A3 (de) Hämoglobinmutanten mit erhöhtem Löslichkeitswert und/oder reduzierter Stickoxidspülung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0537160

Country of ref document: EP

REN Ceased due to non-payment of the annual fee